Hovde associates

Biopharmaceutical R&D is inherently complex. Sound management demands that cost, quality, and time all be carefully considered when evaluating new programs or organizatinal change.

There are many tools and programs proposed to improve cost, quality, and time in pharmaceutical R&D.  Yet the true value of an R&D initiative, especially in clinical research, can be difficult to assess because of the many interactions between cost, quality and time.  For example, it might appear that paying investigators less would save money, but in fact research shows that paying less will delay study completion, thus increasing project management costs and raising total costs.  Careful analysis of cost-quality-time tradeoffs is therefore required before investments and new programs are undertaken. 

Proper consideration of these tradeoffs will avoid sponsor disappointments in the ROI for new programs and initiatives, and spare vendors the burning of precious capital and credibility with ill-considered, uneconomical product and service ideas.

Hovde Associates combines world-class experience with intense microeconomic research to execute the vision of an efficient, cost-effective R&D organization.  Hovde Associates goes beyond mere data and benchmarking to provide real results that bring down costs without compromising the quality and timeliness of drug development programs.

The Hovde Associates team has worked with most major pharmaceutical and biotech companies, as well as important industry service providers including CROs, central labs, SMOs, EDC vendors, and direct-patient recruiters.